Terms: = Prostate cancer AND RAD21, HR21, 5885, ENSG00000164754, KIAA0078, FLJ25655, hHR21, MCD1, O60216, NXP1, HRAD21, FLJ40596, SCC1
10 results:
1. Ductal Adenocarcinoma of the prostate with Novel Genetic Alterations Characterized by Next-Generation Sequencing.
Zara Rozalen A; Martin JM; Rajendran R; Jain M; Nava VE
Curr Oncol; 2024 Mar; 31(3):1556-1561. PubMed ID: 38534951
[TBL] [Abstract] [Full Text] [Related]
2. The Molecular, Immunologic, and Clinicodemographic Landscape of MYC-Amplified Advanced prostate cancer.
Jin WH; Zhang L; Graf R; Raskina K; Tukachinsky H; Huang RSP; McGregor K; Alshalalfa M; Hougen HY; Khan A; Punnen S; Schrock AB; Venstrom J; Mahal BA
Clin Genitourin Cancer; 2024 Feb; 22(1):e163-e169.e1. PubMed ID: 37978032
[TBL] [Abstract] [Full Text] [Related]
3. Clinical significance of atypical
Gossili F; Almasi CE; Zacho HD
Hell J Nucl Med; 2023; 26(2):94-98. PubMed ID: 37527044
[TBL] [Abstract] [Full Text] [Related]
4. Time from biopsy to radical prostatectomy by race in an equal-access healthcare system: Results from the SEARCH cohort.
Pereira V; Oyekunle T; Janes J; Amling CJ; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Klaassen Z; Freedland SJ; Vidal AC; Csizmadi I
Prostate; 2023 Aug; 83(11):1011-1019. PubMed ID: 37096737
[TBL] [Abstract] [Full Text] [Related]
5. Early-onset metastatic and clinically advanced prostate cancer is a distinct clinical and molecular entity characterized by increased TMPRSS2-ERG fusions.
Chalmers ZR; Burns MC; Ebot EM; Frampton GM; Ross JS; Hussain MHA; Abdulkadir SA
Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):558-566. PubMed ID: 33420417
[TBL] [Abstract] [Full Text] [Related]
6. Impact of Insurance Status on Radiation Treatment Modality Selection Among Potential Candidates for prostate, Breast, or Gynecologic Brachytherapy.
Grant SR; Walker GV; Koshy M; Shaitelman SF; Klopp AH; Frank SJ; Pugh TJ; Allen PK; Mahmood U
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):968-75. PubMed ID: 26452570
[TBL] [Abstract] [Full Text] [Related]
7. Development and validation of a fluorogenic assay to measure separase enzyme activity.
Basu D; Zhang N; Panigrahi AK; Horton TM; Pati D
Anal Biochem; 2009 Sep; 392(2):133-8. PubMed ID: 19497291
[TBL] [Abstract] [Full Text] [Related]
8. Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis.
Umbehr M; Bachmann LM; Held U; Kessler TM; Sulser T; Weishaupt D; Kurhanewicz J; Steurer J
Eur Urol; 2009 Mar; 55(3):575-90. PubMed ID: 18952365
[TBL] [Abstract] [Full Text] [Related]
9. TCEB1 promotes invasion of prostate cancer cells.
Jalava SE; Porkka KP; Rauhala HE; Isotalo J; Tammela TL; Visakorpi T
Int J Cancer; 2009 Jan; 124(1):95-102. PubMed ID: 18844214
[TBL] [Abstract] [Full Text] [Related]
10. rad21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer.
Porkka KP; Tammela TL; Vessella RL; Visakorpi T
Genes Chromosomes Cancer; 2004 Jan; 39(1):1-10. PubMed ID: 14603436
[TBL] [Abstract] [Full Text] [Related]
